Medicare Enrolled
Dr. Beverly Demchuk, M.D.
Optician · Neptune, NJ
Practice pattern: Electrophysiology & Device
— Practice focused on heart rhythm disorders and cardiac device management
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Demchuk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Demchuk?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Demchuk
Dr. Beverly Demchuk is an optician specialist in Neptune, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Demchuk performed 6,296 Medicare services across 3,366 unique beneficiaries.
Between the years covered by Open Payments, Dr. Demchuk received a total of $12,205 from 57 pharmaceutical and/or device companies across 485 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Demchuk is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in NJ
$12,205 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,296
Medicare services
Top 9% in NJ for optician
3,366
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~331 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| ECG, 1-3 leads with physician review A simple electrocardiogram recording using one to three leads. A physician reviews the results. |
1,445 | $6 | $40 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,389 | $66 | $155 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
725 | $96 | $187 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
472 | $11 | $98 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
434 | $7 | $30 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
354 | $149 | $280 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
268 | $44 | $85 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
195 | $146 | $317 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
161 | $167 | $850 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
107 | $99 | $190 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
87 | $85 | $110 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
84 | $382 | $815 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
60 | $41 | $95 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
53 | $60 | $375 |
| New patient office visit, complex (60-74 min) | 44 | $184 | $345 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
42 | $110 | $250 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
40 | $165 | $475 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
35 | $22 | $102 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
35 | $160 | $475 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
35 | $34 | $190 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $56 | $155 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
32 | $55 | $440 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
31 | $18 | $65 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
31 | $12 | $50 |
| Cardiac catheterization | 30 | $210 | $625 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
19 | $6 | $20 |
| Emergency department visit, high complexity An emergency department visit involving a high level of medical decision making. |
16 | $147 | $280 |
| Emergency department visit, straightforward decision making An emergency department visit for a patient with a straightforward medical decision making process. |
14 | $35 | $95 |
| Emergency department visit, moderate complexity An emergency department visit for an established or new patient involving a moderate level of medical decision making. |
13 | $101 | $190 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
12 | $67 | $405 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.0% high complexity
10.1% medium
86.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,205
Total received (2018-2024)
Avg $1,744/year across 7 years
Top 8% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
485
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,167 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$38 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,772
2023
$1,261
2022
$1,690
2021
$2,184
2020
$1,514
2019
$2,158
2018
$1,626
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$302
ShockWave Medical, Inc
$236
Kestra Medical Technology Services, Inc.
$191
Abbott Laboratories
$133
BIOTRONIK INC.
$113
SCPHARMACEUTICALS INC.
$106
ABIOMED
$101
Kiniksa Pharmaceuticals International, plc
$82
Janssen Pharmaceuticals, Inc
$78
Novartis Pharmaceuticals Corporation
$70
Amgen Inc.
$49
PFIZER INC.
$36
CVRx, Inc.
$33
Impulse Dynamics (USA) Inc.
$32
Boston Scientific Corporation
$31
HEARTFLOW, INC.
$25
Merck Sharp & Dohme LLC
$21
SANOFI-AVENTIS U.S. LLC
$19
ATRICURE, INC.
$19
Regeneron Healthcare Solutions, Inc.
$18
Philips North America LLC
$18
Novo Nordisk Inc
$16
GlaxoSmithKline, LLC.
$16
Lexicon Pharmaceuticals, Inc.
$14
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 41.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,133
Abbott Laboratories
$1,456
ABIOMED
$1,008
Boehringer Ingelheim Pharmaceuticals, Inc.
$771
Esperion Therapeutics, Inc.
$717
Janssen Pharmaceuticals, Inc
$521
Amgen Inc.
$476
E.R. Squibb & Sons, L.L.C.
$423
Boston Scientific Corporation
$386
Kestra Medical Technology Services, Inc.
$365
Novartis Pharmaceuticals Corporation
$348
Cardiovascular Systems Inc.
$310
PFIZER INC.
$279
Medtronic, Inc.
$260
ShockWave Medical, Inc
$236
SANOFI-AVENTIS U.S. LLC
$205
Kowa Pharmaceuticals America, Inc.
$203
Edwards Lifesciences Corporation
$182
BOSTON SCIENTIFIC CORPORATION
$178
Chiesi USA, Inc.
$169
BIOTRONIK INC.
$152
Novo Nordisk Inc
$119
ARBOR PHARMACEUTICALS, INC.
$111
SCPHARMACEUTICALS INC.
$106
NOVARTIS PHARMACEUTICALS CORPORATION
$87
Kiniksa Pharmaceuticals International, plc
$82
Lundbeck LLC
$76
AngioDynamics, Inc.
$74
Medtronic Vascular, Inc.
$68
Regeneron Healthcare Solutions, Inc.
$63
Saranas, Inc.
$58
Merck Sharp & Dohme Corporation
$44
iRhythm Technologies, Inc.
$39
ATRICURE, INC.
$36
PORTOLA PHARMACEUTICALS, INC.
$34
Kiniksa Pharmaceuticals, Ltd.
$33
CVRx, Inc.
$33
Impulse Dynamics (USA) Inc.
$32
PORTOLA PHARMACEUTICALS, LLC
$29
Daiichi Sankyo Inc.
$26
Cardinal Health 200, LLC
$25
HEARTFLOW, INC.
$25
Merck Sharp & Dohme LLC
$21
Bard Peripheral Vascular, Inc.
$18
CORDIS US CORP.
$18
Philips North America LLC
$18
GlaxoSmithKline, LLC.
$16
Akcea Therapeutics, Inc.
$15
Allergan Inc.
$14
Alexion Pharmaceuticals, Inc.
$14
Lexicon Pharmaceuticals, Inc.
$14
Alnylam Pharmaceuticals Inc.
$14
MEDICOMP INC
$14
Gilead Sciences, Inc.
$13
CHIESI USA, INC.
$13
Actelion Pharmaceuticals US, Inc.
$13
ARALEZ PHARMACEUTICALS US INC.
$12
Top 3 companies account for 37.7% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · ANDEXXA · AREXVY · ATRICLIP LAA EXCLUSION SYSTEM · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Acticor · Andexxa · Arcalyst · Asahi Fielder coronary guide wire · Assure WCD · BEVYXXA · BIOMONITOR · BRILINTA · BRITE TIP RADIANZ · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · COMET · Cardiac Monitor · Corlanor · Coronary Orbital Atherectomy System · ELIQUIS · ELUVIA · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FUROSCIX · General - Ultrasound · HawkOne · HeartMate · INJECTAFER · Impella · JARDIANCE · KENGREAL · KENGREAL 50MG/10ML L · LEQVIO · Livalo · MICRA · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · MynxGrip Vascular Closure Device · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · Optimizer · Optis Coronary Imaging System · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · PressureWire FFR · Quadra Assura CRT Defibrillator · RESONATE · REVEAL LINQ · Repatha · Resolute · Rybelsus · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TEGSEDI · UPTRAVI · VARITHENA · VERQUVO · VYNDAQEL · Varithena Administration Pack · Venclose Maven Catheter · WATCHMAN · Wegovy · XARELTO · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · Xience cornary stent systems · ZIO Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for optician in NJ.
Geographic Context
Opticians within 10 mi
677
Per 100K population
105.2
County median income
$122,727
Nearest hospital
MONMOUTH MEDICAL CENTER
7.4 mi
7.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Demchuk is an electrophysiology & device specialist, with above-average Medicare volume (top 9% in NJ), with low-engagement industry engagement in the top 8% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Demchuk experienced with ecg, 1-3 leads with physician review?
Based on Medicare claims data, Dr. Demchuk performed 1,445 ecg, 1-3 leads with physician review services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Demchuk receive payments from pharmaceutical companies?
Yes. Dr. Demchuk received a total of $12,205 from 57 companies across 485 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Demchuk's costs compare to other opticians in Neptune?
Dr. Demchuk's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Demchuk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Neptune
Browse opticians in Neptune ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology